AccuSift provides high‑performance tadalafil competitive assay pairings, characterized by exceptional batch‑to‑batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.Tadalafil is a selective reversible inhibitor of cyclic guanosine monophosphate (cGMP)‑specific phosphodiesterase type 5 (PDE5). When sexual stimulation causes local nitric oxide release, PDE5 is inhibited by tadalafil, leading to elevated cGMP levels in the corpus cavernosum. This results in smooth muscle relaxation, increased blood flow into penile tissue, and erection; without sexual stimulation, the drug may not exert its effect.In June 2025, the State Administration for Market Regulation, jointly with the National Health Commission, issued an announcement adding nafil‑type and lafil‑type substances to the list of non‑edible substances that may be illegally added to food. This measure aims to strictly crack down on the illegal addition of nafil‑type and lafil‑type substances during food production and operation, effectively safeguarding consumer rights.Performance Characteristics:
Sensitivity: ELISA IC50: 2 ppb
Source: Mouse Monoclonal Antibody
Recommended Pairing: (Coating) / (Labeling)
Storage: Long‑term storage at ≤ –20°C; short‑term storage at 2–8°C. Shipped on ice packs.
WeChat
